Falls and Physical Performance Deficits in Older Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy

Urology

Volumn 72, Issue 2, 2008, Pages 422-427

  Bylow, Kathryn ^a   Dale, William ^b   Mustian, Karen ^c   Stadler, Walter M ^b   Rodin, Miriam ^e   Hall, William ^d   Lachs, Mark ^f   Mohile, Supriya G ^c,d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

ADL DISABILITY; AGE DISTRIBUTION; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER HORMONE THERAPY; COGNITIVE DEFECT; CONTROLLED STUDY; FALLING; FATIGUE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; KATZ INDEX; LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSTATE CANCER; UNIVARIATE ANALYSIS; VULNERABLE POPULATION;

ACCIDENTAL FALLS; ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PHYSICAL FITNESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 48349102661     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.03.032     Document Type: Article

References (37)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Post P.N., Kil P.J., Hendrikx A.J., et al. Comorbidity in patients with prostate cancer and its relevance to treatment choice. BJU Int 84 (1999) 652-656
3. Newschaffer C.J., Otani K., McDonald M.K., et al. Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 92 (2000) 613-621
4. McLeod D., Zinner N., Tomera K., et al. A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer. Urology 58 (2001) 756-761
5. Peeling W.B. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma. Urology 33 (1989) 45-52
6. Shahinian V.B., Kuo Y.F., Freeman J.L., et al. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer 103 (2005) 1615-1624
7. Studer U.E., Hauri D., Hanselmann S., et al. Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: Results of the randomized trial SAKK 08/88. J Clin Oncol 22 (2004) 4109-4118
8. Mohile S.G., Bylow K., Dale W., et al. A pilot study of the Vulnerable Elders Survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 109 (2007) 802-810
9. Bubley G.J., Carducci M., Dahut W., et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 17 (1999) 3461-3467
10. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of Adl: A standardized measure of biological and psychosocial function. JAMA 185 (1963) 914-919
11. Lawton M.P. Scales to measure competence in everyday activities. Psychopharmacol Bull 24 (1988) 609-614
12. Saliba D., Elliott M., Rubenstein L.Z., et al. The Vulnerable Elders Survey: A tool for identifying vulnerable older people in the community. J Am Geriatr Soc 49 (2001) 1691-1699
13. Guralnik J.M., Simonsick E.M., Ferrucci L., et al. A Short Physical Performance Battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49 (1994) M85-M94
14. Guralnik J.M., Ferrucci L., Simonsick E.M., et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332 (1995) 556-561
15. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23 (1975) 433-441
16. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40 (1987) 373-383
17. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
18. Cabrera M.A., Mesas A.E., Garcia A.R., et al. Malnutrition and depression among community-dwelling elderly people. J Am Med Dir Assoc 8 (2007) 582-584
19. Stump T.E., Callahan C.M., and Hendrie H.C. Cognitive impairment and mortality in older primary care patients. J Am Geriatr Soc 49 (2001) 934-940
20. Clay C.A., Perera S., Wagner J.M., et al. Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther 87 (2007) 1325-1333
21. Donald I.P., and Bulpitt C.J. The prognosis of falls in elderly people living at home. Age Ageing 28 (1999) 121-125
22. Chan B.K., Marshall L.M., Winters K.M., et al. Incident fall risk and physical activity and physical performance among older men: The Osteoporotic Fractures in Men Study. Am J Epidemiol 165 (2007) 696-703
23. Terret C., Albrand G., and Droz J.P. Geriatric assessment in elderly patients with prostate cancer. Clin Prostate Cancer 2 (2004) 236-240
24. Tinetti M.E. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34 (1986) 119-126
25. Joly F., Alibhai S.M., Galica J., et al. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 176 (2006) 2443-2447
26. Butland R.J., Pang J., Gross E.R., et al. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ Clin Res Ed 284 (1982) 1607-1608
27. Podsiadlo D., and Richardson S. The timed "Up & Go": A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39 (1991) 142-148
28. Janssen H.C., Samson M.M., and Verhaar H.J. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75 (2002) 611-615
29. Schwartz G.G. Vitamin D and the epidemiology of prostate cancer. Semin Dial 18 (2005) 276-289
30. Dhesi J.K., Bearne L.M., Moniz C., et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 17 (2002) 891-897
31. Bischoff H.A., Stahelin H.B., Dick W., et al. Effects of vitamin D and calcium supplementation on falls: A randomized controlled trial. J Bone Miner Res 18 (2003) 343-351
32. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56 (2001) M146-M156
33. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults: The cardiovascular Health Study. JAMA 279 (1998) 585-592
34. Bylow K., Mohile S.G., Stadler W.M., et al. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?. A conceptual review. Cancer (2007)
35. Daniell H.W. Osteoporosis due to androgen deprivation therapy in men with prostate cancer. Urology 58 (2001) 101-107
36. Smith J.C., Bennett S., Evans L.M., et al. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab 86 (2001) 4261-4267
37. Smith M.R., Finkelstein J.S., McGovern F.J., et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 87 (2002) 599-603